Bellingbio continuously challenges ourselves, using the power of innovation to drive the development of the bile acid series fields. After two decades of effort, we have formed a comprehensive industrial chain layout from the R&D of bile acid series and the production of active pharmaceutical ingredients (APIs) to the R&D of preparations.

        As a domestic enterprise focused on the production of bile acid APIs, Bellingbio's annual capacity of active substance starting material and APIs of bile acid series has reached thousands of tons. Specifically, the annual capacity of Ursodeoxycholic Acid is 420 tons/year, Chenodeoxycholic Acid is 600 tons/year, and Cholic Acid is 100 tons/year. Commercial production line and lean production management ensure the annual capacity and reduce manufacturing costs, providing customers with cost-effective but high quality products. Bellingbio attentively listens to the needs of every customer and wins the trust and support of customers with professional services. Our leading product, Ursodeoxycholic Acid API, holds top one in China market and within top three in global market, with customers spread across nearly 50 countries and regions worldwide, including Germany, Czech Republic, Russia, India, the United States, Canada, Japan, Argentina, Egypt, Australia, Brazil etc.

BELLINGBIO R&D CENTER：

R&D Department 1: Chemical synthesis of active substances of bile acid series and R&D of bio-enzymes.

R&D Department 2: R&D and structure of high-efficiency bio-enzymes and microchannel reaction platforms.

Preparation R&D Department: R&D of preparations of bile acid series.

Xianhe Pharmaceutical: R&D of APIs and pharmaceutical preparations.